SEC Form 4 · accession 0001140361-15-019549
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sue Bailey
Director
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 11:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2015 | M | 5,760 | $8.43 | A | 24,860 | D | |
| Common StockF1,F2 | May 12, 2015 | S | 5,760 | $30.14 | D | 19,100 | D | |
| Common StockF3 | May 12, 2015 | M | 6,960 | $8.76 | A | 26,060 | D | |
| Common StockF3,F2 | May 12, 2015 | S | 6,960 | $30.13 | D | 19,100 | D | |
| Common StockF4 | May 12, 2015 | M | 5,760 | $11.67 | A | 24,860 | D | |
| Common StockF4,F2 | May 12, 2015 | S | 5,760 | $30.08 | D | 19,100 | D | |
| Common StockF5 | May 12, 2015 | M | 1,440 | $16.13 | A | 20,540 | D | |
| Common StockF5,F2 | May 12, 2015 | S | 1,440 | $30.16 | D | 19,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F6 | $8.43 | May 12, 2015 | M | 5,760 | D | Jun 14, 2008 | Jun 13, 2017 | Common Stock | 5,760 | 1,440 | D |
| Stock OptionF3,F6 | $8.76 | May 12, 2015 | M | 6,960 | D | May 21, 2009 | May 20, 2018 | Common Stock | 6,960 | 4,640 | D |
| Stock OptionF4,F6 | $11.67 | May 12, 2015 | M | 5,760 | D | May 21, 2010 | May 21, 2019 | Common Stock | 5,760 | 8,640 | D |
| Stock OptionF5,F6 | $16.13 | May 12, 2015 | M | 1,440 | D | May 20, 2011 | May 20, 2010 | Common Stock | 5,760 | 5,760 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on June 14, 2007.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $30.24, inclusive.
- F3Consists of an option granted under the company's stock incentive plan on May 21, 2008.
- F4Consists of an option granted under the company's stock incentive plan on May 21, 2009.
- F5Consists of an option granted under the company's stock incentive plan on May 20, 2010.
- F6All options vested in three equal installments on the anniversary date of the grant.